Cell Signaling Technology

Phospho-NMDA Receptor 1 (GluN1) (Ser896) Antibody

#3384 · $362

100
Citing papers
15.1k
Combined citations
Supplier page Find this product

Research areas

Neuroinflammation and Neurodegeneration Mechanisms14MicroRNA in disease regulation8Immune Cell Function and Interaction8Parkinson's Disease Mechanisms and Treatments6Cancer Immunotherapy and Biomarkers6Immunotherapy and Immune Responses6Autophagy in Disease and Therapy6RNA modifications and cancer6

Papers citing this product

1
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
PLoS ONE·2009·1k cit.·DOI
2
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell·2020·811 cit.·DOI
3
PINK1 cleavage at position A103 by the mitochondrial protease PARL
Human Molecular Genetics·2010·485 cit.·DOI
4
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Journal of Neuroscience·2016·477 cit.·DOI
5
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Nature·2014·455 cit.·DOI
6
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
Biochemical Journal·2010·402 cit.·DOI
7
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Journal of Clinical Investigation·2019·380 cit.·DOI
8
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke
Journal of Neuroscience·2015·375 cit.·DOI
9
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Journal of Neuroscience·2011·268 cit.·DOI
10
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Nature·2012·257 cit.·DOI
Phospho-NMDA Receptor 1 (GluN1) (Ser896) Antibody — Evidence — PubIndex